Cytosorbents Corp at Cowen Healthcare Conference (Virtual) Transcript
Good afternoon. I'm Josh Jennings from the medical devices team, representing Neil Chatterji, Brian Kennedy and Eric Anderson as well. We're moving through the medical devices track here at the 41st Annual Cowen Health Care Conference, and we're excited to have the Chief Executive Officer of CytoSorbents, Dr. Phil Chan, joining us today.
We're going to -- he's going to run through some introductory slides for investors that are new to story and provide some updates, and then we'll move right into the Q&A.
Phil, I'll hand it right over to you. Thanks so much for being here.
Yes. Absolutely. And thank you very much, Josh, for the invitation. So I am Dr. Phillip Chan. And before I start, let me please remind viewers our safe harbor statement for forward-looking statements.
CytoSorbents is leading the prevention or treatment of life-threatening inflammation
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |